Abstract:Objective To investigate the effect of combinatorial therapy with adenoviral-mediated phosphatase and tensin homologue deleted on chromosometen (PTEN) and a phosphoinositide 3-kinase (PI3K) inhibitor LY294002 suppresses malignant glioma cell LN229 proliferation and invasion by regulating the PTEN/PI3K/protein kinase B (Akt) signaling pathway.Methods Ad-PTEN and LY294002 were transfected into LN229 malignant glioma cells,and they were used to detect the proliferative activity of the LN229 cells by methyl thiazol tetrazolium (MTF) and flow cytometry.The invasion ability of LN229 cells was examined by Transwell test.Western blotting analysis was used to detect the protein expression in PTEN/PI3K/Akt signal pathway.Results Compared with Ad-vector,dmethyl sulfoxide (DMSO) and LY294002 group,the MTT assay showed that the cell growth was significantly inhibited in the combination group and the cell proliferation rate was only 38.68％ on the six day.The cell cycle analysis showed that the DNA contents of cell G0/G1 phase in the combination group was 75.49％ . It was higher than 51.62％,50.31％ and 66.35％ in the Ad-vector,DMSO and LY294002 group.There were significant differences (P ＜0.05).The Transwell assay decreased obviously,and there were only 15.58 ± 1.45.It was lower than 27.63 ±4.36,46.67 ±3.61 and 49.28 ±5.37 in the Ad-vector,DMSO and LY294002 group.There were significant differences (P ＜ 0.05).Western blotting assay showed that the relative expression quantities of PTEN were 0.13 ± 0.04,0.26 ± 0.03,0.52 ± 0.07 and 0.83 ± 0.16,respectively;and the relative expression quantities of phosphorylated protein kinase B (p-Akt) were 1.30 ± 0.07,1.73 ±0.07,0.87 ±0.17 and 0.35 ±0.08,respectively;and the relative expression quantities of proliferating cell nuclear antigen (PCNA) were 2.72 ±0.02,3.13 ±0.06,0.63 ±0.13 and 0.38 ±0.09,respectively;and the relative expression quantities of Cyclin D1 were 1.72 ± 0.09,1.18 ± 0.15,0.49 ± 0.11 and 0.18 ±0.14,respectively;and the relative expression quantities of phosphorylated focal adhesion kinase (p-FAK) were 0.95 ± 0.14,1.09 ± 0.16,1.29 ± 0.08 and 0.65 ± 0.1 1,respectively;and the relative expression quantities of matrix metalloproteinase (MMP)-2 were 0.73 ± 0.19,0.87 ± 0.12,0.61 ± 0.10 and 0.23 ± 0.08,respectively;There were significant differences (P ＜ 0.05).Conclusion Combining use of LY294002 and Ad-PTEN can suppresses malignant glioma cell proliferation and invasion by regulating the PTEN/PI3K/Akt signaling pathway.

Sensitization Of Glioma Cells To Tamoxifen-Induced Apoptosis By Pl3-Kinase Inhibitor Through The Gsk-3 Beta/Beta-Catenin Signaling Pathway

Enhanced Proliferation Inhibition and Apoptosis in Glioma Cells Elicited by Combination of Irinotecan and Imatinib

PI3K Inhibitor Combined with Mir-125B Inhibitor Sensitize TMZ-induced Anti-Glioma Stem Cancer Effects Through Inactivation of Wnt/β-catenin Signaling Pathway

Gefitinib-Resistance is Related to Bim Expression in Non-Small Cell Lung Cancer Cell Lines

Tamoxifen-induced Apoptosis of Rat C6 Glioma Cells Via PI3K/Akt, JNK and ERK Activation.

BIM Induction of Apoptosis Triggered by EGFR-sensitive and Resistance Cell Lines of Non-Small-cell Lung Cancer

The Effects of combined therapy of Phosphatidylinositol 3p-Kinase inhibitor and Ad-PTEN in human glioma nude mice model

Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation

PTEN Activation Sensitizes Breast Cancer to PI3-kinase Inhibitor Through the Β-Catenin Signaling Pathway

STAT3 inhibition induced temozolomide-resistant glioblastoma apoptosis via triggering mitochondrial STAT3 translocation and respiratory chain dysfunction.

Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX

Pten Restoration and Pik3cb Knockdown Synergistically Suppress Glioblastoma Growth in Vitro and in Xenografts

Correction To: Synergism Between the Phosphatidylinositol 3-Kinase P110β Isoform Inhibitor AZD6482 and the Mixed Lineage Kinase 3 Inhibitor URMC-099 on the Blockade of Glioblastoma Cell Motility and Focal Adhesion Formation

Radiosensitization of Human Glioma Cells by Tamoxifen is Associated with the Inhibition of PKC-ι Activity in Vitro.

Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide

Mechanism study of combinatorial therapy suppresses malignant glioma cell proliferation and invasion by regulating the phosphatase and tensin homologue deleted on chromosometen/phosphoinositide 3-kinase/protein kinase B signaling pathway

Two Specific Inhibitors of the Phosphatidylinositol 3-Kinase LY294002 and Wortmannin Up-Regulate Β1,4-Galactosyltransferase I and Thus Sensitize SMMC-7721 Human Hepatocarcinoma Cells to Cycloheximide-Induced Apoptosis

Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.

P53 Upregulated Modulator of Apoptosis Sensitizes Drug-Resistant U251 Glioblastoma Stem Cells to Temozolomide Through Enhanced Apoptosis.

A high-throughput drug combination screen identifies an anti-glioma synergism between TH588 and PI3K inhibitors

MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway